12:00 AM
Sep 29, 2008
 |  BC Week In Review  |  Company News  |  Deals

Arca biopharma, Nuvelo deal

Nuvelo and cardiovascular company Arca agreed to reverse merge. Arca shareholders will own 67% of the combined company, and Nuvelo shareholders will own 33%. The combined company will retain Arca's name and headquarters and will apply for a new NASDAQ ticker. Richard Brewer, president and CEO of Arca, will become...

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >